Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(19)
MIXED(8)
68Ga-P16-093
5 trials
not_applicablephase_1_2phase_2_3
peking-union-medical-college-hospital
68Ga-FAPI
3 trials
phase_1phase_1_2
peking-union-medical-college-hospital
68Ga-PSMA
2 trials
early_phase_1not_applicable
peking-union-medical-college-hospital
1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
2 trials
early_phase_1not_applicable
peking-union-medical-college-hospital
1.1 GBq (30 mCi) of 177Lu-P17-087
1 trial
early_phase_1
peking-union-medical-college-hospital
68Ga-NOTA-PRGD2
1 trial
early_phase_1
peking-union-medical-college-hospital
68Ga-BMV101
1 trial
early_phase_1
peking-union-medical-college-hospital
[68Ga]Ga-HBED-CC-exendin-4
1 trial
early_phase_1
peking-union-medical-college-hospital

+11 more interventions

19 unique interventions2 categories

Analytics

Trial Phases

Phase 16
Phase 26
Phase 31

Trial Status

Completed2
Recruiting5
Other12

Role Distribution

Principal Investigator18
Other Roles1
PI Rate95%

Activity Timeline

Clinical Trials (19)

NCT07498933Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors
Neoadjuvant TherapyNon-Small Cell Lung CancerPET/CT
PrincipalinvestigatorStart date: 2025-06-03
NCT07062523Phase 1/2Recruiting
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
Sjogren's Syndrome
StudychairStart date: 2024-07-01
NCT06250244Phase 1/2Unknown
177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
PrincipalinvestigatorStart date: 2023-05-01
NCT05603559Early Phase 1Recruiting
177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
PrincipalinvestigatorStart date: 2023-01-01
NCT05324332Not ApplicableRecruiting
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
Prostate Cancer
PrincipalinvestigatorStart date: 2022-04-15
NCT05432947Not ApplicableCompleted
68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients
Clear Cell Renal Cell Carcinoma
PrincipalinvestigatorStart date: 2022-04-14
NCT05275699Phase 1/2Completed
Analyse of Diagnosis Value of Keloid on 68Ga- FAPI-04 PET-CT
Keloid
PrincipalinvestigatorStart date: 2022-03-01
NCT05170555Not ApplicableUnknown
Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617
Renal Cell Carcinoma
PrincipalinvestigatorStart date: 2021-12-01
NCT05569434Phase 1/2Unknown
68Ga-P16-093 PET/CT Imaging in Glioma Patients
Glioma
PrincipalinvestigatorStart date: 2021-11-28
NCT05121779Phase 1Recruiting
Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT
Pulmonary Fibrosis
PrincipalinvestigatorStart date: 2021-11-18

Showing 10 of 19 trials

Research Network

Collaboration Network

18 collaborators·29 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hao Li, MD

Peking University People's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTNeoadjuvant Therapy

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score34%

Yuan Li, MD

Peking University People's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTNeoadjuvant Therapy

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score34%

Kezhong Chen, MD

Peking University People's Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTNeoadjuvant Therapy

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score34%

Jun Wang, M.M.

Peking University People's Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTNeoadjuvant Therapy

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score34%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerMetastatic Castration-resistant Prostate CancerClear Cell Renal Cell Carcinoma+1 more
Similarity Score7%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GliomaCarcinoma, Non-Small-Cell LungPulmonary Fibrosis+1 more
Similarity Score7%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Prostate CancerMetastatic Castration-resistant Prostate CancerCarcinoma, Non-Small-Cell Lung
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungProstate Cancer

Worked with same sponsors:

Beijing Tiantan HospitalPeking University People's Hospital
Similarity Score4%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerClear Cell Renal Cell Carcinoma
Similarity Score4%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Prostate CancerCarcinoma, Non-Small-Cell Lung
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (19)

Showing 19 of 19 trials

NCT07498933PrincipalInvestigator

FAP-targeted PET/NIR in Lung Malignant Tumors

Neoadjuvant TherapyNon-Small Cell Lung CancerPET/CT
Recruiting
NCT07062523Phase 1/2StudyChair

Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT

Sjogren's Syndrome
Recruiting
NCT06250244Phase 1/2PrincipalInvestigator

177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer
Unknown
NCT05603559Early Phase 1PrincipalInvestigator

177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer
Recruiting
NCT05324332Not ApplicablePrincipalInvestigator

68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients

Prostate Cancer
Recruiting
NCT05432947Not ApplicablePrincipalInvestigator

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Clear Cell Renal Cell Carcinoma
Completed
NCT05275699Phase 1/2PrincipalInvestigator

Analyse of Diagnosis Value of Keloid on 68Ga- FAPI-04 PET-CT

Keloid
Completed
NCT05170555Not ApplicablePrincipalInvestigator

Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617

Renal Cell Carcinoma
Unknown
NCT05569434Phase 1/2PrincipalInvestigator

68Ga-P16-093 PET/CT Imaging in Glioma Patients

Glioma
Unknown
NCT05121779Phase 1PrincipalInvestigator

Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT

Pulmonary Fibrosis
Recruiting
NCT05013086Early Phase 1PrincipalInvestigator

177Lu-AB-3PRGD2 in Patients With Integrin αVβ3 Positive Tumors

Integrin αVβ3 Positive Tumors
Unknown
NCT05034783Early Phase 1PrincipalInvestigator

[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients

Insulinoma
Unknown
NCT04796467Phase 2/3PrincipalInvestigator

68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

Prostate Cancer
Unknown
NCT04801264Early Phase 1PrincipalInvestigator

Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617

Adenoid Cystic Carcinoma
Unknown
NCT04996602Early Phase 1PrincipalInvestigator

Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC

Prostate Cancer
Unknown
NCT01801371Early Phase 1PrincipalInvestigator

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma

Glioma
Unknown
NCT02485886Early Phase 1PrincipalInvestigator

68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
Unknown
NCT02511197Early Phase 1PrincipalInvestigator

68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis

Pulmonary Fibrosis, Unspecified
Unknown
NCT06049368Phase 1/2PrincipalInvestigator

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Primary Sjögren Syndrome
Unknown

All 19 trials loaded